분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2019-02-07 17:31:13 , Hit : 1112
 CRISPR-Cas9 Inhibitors Found in Metagenomics Study

https://www.genengnews.com/news/crispr-cas9-inhibitors-found-in-metagenomics-study/

February 6, 2019

Anti-CRISPR proteins could be harnessed to improve CRISPR gene editing systems by reducing their off-target effects, and by controlling when and where they act. Anti-CRISPR proteins, however, are rare in nature—or simply hard to find. In hopes of adding to the few anti-CRISPR proteins already discovered, scientists based at the Technical University of Denmark tried a new kind of search. In doing so, they may have avoided the streetlight effect, a kind of observational bias that occurs when people search for something only where it seems obvious to look.

Instead of a streetlight’s illumination limiting a search for lost keys, for example, the usual anti-CRISPR search strategy—examining the contents of phage DNA—could hamper the search for CRISPR inhibitors. So, rather than use the usual strategy, the scientific team at the Technical University of Denmark used a genetic circuit to select anti-CRISPR genes from metagenomes. The team, led by Morten O.A. Sommer, who is also affiliated with the Novo Nordisk Foundation Center for Biosustainability, succeeded in discovering four CRISPR-Cas9 inhibitors.

Detailed findings appeared February 5 in Cell Host & Microbe, in an article titled, “Discovery and Characterization of Cas9 Inhibitors Disseminated across Seven Bacterial Phyla.” The article described how a synthetic genetic circuit enabled a high-throughput investigation of anti-CRISPR genes from metagenomic libraries. This investigation, the article emphasized, was based on functional activity rather than sequence homology or genetic context.

“We identified 11 DNA fragments from soil, animal, and human metagenomes that circumvent Streptococcus pyogenes Cas9 activity in our selection strain,” the article’s authors wrote. “Further in vivo and in vitro characterization of a subset of these hits validated the activity of four anti-CRISPRs.”

The DNA was chopped into smaller pieces and randomly expressed on a plasmid within a bacterial cell. This cell contained a genetic circuit for selection of anti-CRISPR activity. In short, this meant that cells containing a plasmid with a potential anti-CRISPR gene would become resistant to a certain antibiotic. On the contrary, cells in which the plasmid did not confer anti-CRISPR-activity would die. With this system, the researchers could easily detect and select DNA with anti-CRISPR activity and trace it back to its origin.





  



Further characterization could then confirm the activity of four new anti-CRISPRs. Phylogenetic analysis revealed that the genes identified in the fecal samples are present in bacteria found in multiple environments, for instance in bacteria living in insects’ gut, seawater, and food. This shows that the newly discovered genes are spread in many bacterial branches in the tree of life, and in some cases with evidence that some of these genes have been horizontally transferred numerous times during evolution.


Graphical abstract from a study describing the discovery and characterization of Cas9 inhibitors. The study showed that anti-CRISPRs against type II-A CRISPR-Cas systems are widely distributed across bacterial phyla, suggesting a more complex ecological role than previously appreciated. [Cell Host & Microbe]
“The fact that the anti-CRISPRs we discovered are so abundant in nature suggests that they are very useful and have a big significance from a biological perspective,” said Sommer.

These findings suggest that anti-CRISPRs could likely play a much bigger role in the interplay between phage and host than what has previously been suggested.

Earlier studies in this field have demonstrated that anti-CRISPR proteins can be used to reduce errors, such as cutting DNA at off-target sites, when doing genome editing in the laboratory.

“Today, most researchers using CRISPR-Cas9 have difficulties controlling the system and off-target activity. Therefore, anti-CRISPR systems are very important, because you want to be able to turn your system on and off to test the activity. Therefore, these new proteins could become very useful,” Sommer noted.

The researchers actually discovered that the four new anti-CRISPR proteins seem to have different traits and properties. Going forward, this will be very exciting to investigate further.








1087   microRNA가 췌장암 치료제가 될 수 있을까  이성욱 2015/06/30 1052
1086   Drug flushes out hidden AIDS virus  이성욱 2015/03/07 1055
1085   융합연구리뷰 | Convergence Research Review  이성욱 2016/01/08 1058
1084   [바이오토픽] 브로드 연구소, 열띤 CRISPR 특허전쟁에서 승리  이성욱 2017/02/16 1060
1083   정밀의학의 끝: 개인화된 종양백신을 개발하는 과학자들  이성욱 2016/04/26 1061
1082   유전자치료제 연구개발 및 규제 동향 2015-식품의약품안전처  이성욱 2016/01/20 1067
1081   Gilead hepatitis C drug highly effective in cirrhosis patients  이성욱 2014/11/14 1068
1080   [바이오토픽] C형간염을 3주 만에 치료하는 DAA 3제요법  이성욱 2015/11/02 1070
1079   미국 과학·공학·의학 아카데미, 「GM 베이비」의 진행방향에 대한 윤곽 발표  이성욱 2017/02/16 1073
1078   진화와 질병치료 연구를 진전시킬 새로운 유전 메커니즘  이성욱 2015/02/06 1074
1077   일본의 검증팀 STAP 세포 재현 포기, 오보카타 사임  이성욱 2014/12/23 1075
1076   세계 20여 개국 과학자들, 유전자편집 정상회담 개최  이성욱 2015/12/05 1079
1075   CRISPR Structure Data Reveal How Cas Enzymes Choose Target  이성욱 2017/07/25 1088
1074   암 생존율을 높일 수 있는 면역세포  이성욱 2014/12/16 1091
1073   옥스포드 나노포어, 휴대용 시퀀서 미니온 출시 임박  이성욱 2015/05/08 1091
1072   Chinese Scientists To Test Gene Modifying Technique ‘CRISPR’ On Humans For The First Time  이성욱 2016/07/27 1095
1071   네안데르탈인과 이웃에 살았던 현생인류의 두개골 발견  이성욱 2015/02/03 1097
1070   [미국] 유전자가위 규제 마련 지연과 기업들의 움직임  이성욱 2016/07/21 1104
1069   유전자편집치료에 희망을 준 백혈병치료  이성욱 2015/11/11 1107
1068   인류의 역사를 고스란히 보여주는 결핵균의 게놈  이성욱 2015/01/21 1110

[1][2][3][4][5][6][7][8][9] 10 ..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN